OnCo
technologiesTechnologyStandard of care

Community oncology and site networks

The clinics where most cancer patients are actually treated, increasingly organised into large networks that also run trials.

In the US, over half of patients are treated in community practices organised by The US Oncology Network (McKesson), OneOncology (TPG/AmerisourceBergen), Florida Cancer Specialists, American Oncology Network, and hospital systems; Sarah Cannon Research Institute (HCA/McKesson JV) and NCI's NCORP bring trials to them. Vertical integration with distributors and payer models (Enhancing Oncology Model) shape drug choice and trial access.

Generic schematic · not to scale · placeholder for the supportive care front
Structured aerobic + resistance

How it works

Networked practices share EHR, pathways, purchasing, and research infrastructure to deliver care close to home.

Strengths
  • Access near home
  • Large trial-eligible populations
Limitations
  • Variable adoption of new biomarker testing
  • Consolidation and drug-margin incentives

Key papers

1top

Latest papers

top
Latest papers · live from Europe PMC
Open in Europe PMC

Query for this technology: (TITLE:"Community oncology and site networks" OR ABSTRACT:"Community oncology and site networks") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Community oncology and site networks, not a curated reading list.

Connected

14top

Pages like this

not linked directly; found by shared links